Downregulation of SULF1 mRNA in ovarian cancer cells, achieved via siRNA, reduces sensitivity to cisplatin-induced cytotoxicity, indicating that loss of SULF1 mRNA promotes chemoresistance. This evidence concerns the gene SULF1 and ovarian cancer.